These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 24931439)

  • 1. Recent advances using zebrafish animal models for muscle disease drug discovery.
    Maves L
    Expert Opin Drug Discov; 2014 Sep; 9(9):1033-45. PubMed ID: 24931439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple animal models for amyotrophic lateral sclerosis drug discovery.
    Patten SA; Parker JA; Wen XY; Drapeau P
    Expert Opin Drug Discov; 2016 Aug; 11(8):797-804. PubMed ID: 27249162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duchenne muscular dystrophy animal models for high-throughput drug discovery and precision medicine.
    Wasala NB; Chen SJ; Duan D
    Expert Opin Drug Discov; 2020 Apr; 15(4):443-456. PubMed ID: 32000537
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel chemical-combination screen in zebrafish identifies epigenetic small molecule candidates for the treatment of Duchenne muscular dystrophy.
    Farr GH; Morris M; Gomez A; Pham T; Kilroy E; Parker EU; Said S; Henry C; Maves L
    Skelet Muscle; 2020 Oct; 10(1):29. PubMed ID: 33059738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug screening in a zebrafish model of Duchenne muscular dystrophy.
    Kawahara G; Karpf JA; Myers JA; Alexander MS; Guyon JR; Kunkel LM
    Proc Natl Acad Sci U S A; 2011 Mar; 108(13):5331-6. PubMed ID: 21402949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Novel Therapeutics for Muscular Dystrophies using Zebrafish Phenotypic Screens.
    Widrick JJ; Kawahara G; Alexander MS; Beggs AH; Kunkel LM
    J Neuromuscul Dis; 2019; 6(3):271-287. PubMed ID: 31282429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Swimming into prominence: the zebrafish as a valuable tool for studying human myopathies and muscular dystrophies.
    Gibbs EM; Horstick EJ; Dowling JJ
    FEBS J; 2013 Sep; 280(17):4187-97. PubMed ID: 23809187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle diseases in the zebrafish.
    Lin YY
    Neuromuscul Disord; 2012 Aug; 22(8):673-84. PubMed ID: 22647769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.
    Kornegay JN; Spurney CF; Nghiem PP; Brinkmeyer-Langford CL; Hoffman EP; Nagaraju K
    ILAR J; 2014; 55(1):119-49. PubMed ID: 24936034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of drug modifiers for RYR1-related myopathy using a multi-species discovery pipeline.
    Volpatti JR; Endo Y; Knox J; Groom L; Brennan S; Noche R; Zuercher WJ; Roy P; Dirksen RT; Dowling JJ
    Elife; 2020 Mar; 9():. PubMed ID: 32223895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dystrophin-deficient zebrafish feature aspects of the Duchenne muscular dystrophy pathology.
    Berger J; Berger S; Hall TE; Lieschke GJ; Currie PD
    Neuromuscul Disord; 2010 Dec; 20(12):826-32. PubMed ID: 20850317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Discovery of Therapies for Duchenne Muscular Dystrophy.
    Blat Y; Blat S
    J Biomol Screen; 2015 Dec; 20(10):1189-203. PubMed ID: 25975656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle dysfunction in a zebrafish model of Duchenne muscular dystrophy.
    Widrick JJ; Alexander MS; Sanchez B; Gibbs DE; Kawahara G; Beggs AH; Kunkel LM
    Physiol Genomics; 2016 Nov; 48(11):850-860. PubMed ID: 27764767
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent progress in the use of zebrafish for novel cardiac drug discovery.
    Keßler M; Rottbauer W; Just S
    Expert Opin Drug Discov; 2015; 10(11):1231-41. PubMed ID: 26294375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and cell-based therapy for Duchenne muscular dystrophy in humans, mice, and zebrafish.
    Kunkel LM; Bachrach E; Bennett RR; Guyon J; Steffen L
    J Hum Genet; 2006; 51(5):397-406. PubMed ID: 16583129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.
    Waugh TA; Horstick E; Hur J; Jackson SW; Davidson AE; Li X; Dowling JJ
    Hum Mol Genet; 2014 Sep; 23(17):4651-62. PubMed ID: 24760771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duchenne muscular dystrophy drug discovery - the application of utrophin promoter activation screening.
    Moorwood C; Khurana TS
    Expert Opin Drug Discov; 2013 May; 8(5):569-81. PubMed ID: 23473647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of birefringence readily measures the level of muscle damage in zebrafish.
    Berger J; Sztal T; Currie PD
    Biochem Biophys Res Commun; 2012 Jul; 423(4):785-8. PubMed ID: 22713473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zebrafish based small molecule screens for novel DMD drugs.
    Kawahara G; Kunkel LM
    Drug Discov Today Technol; 2013; 10(1):e91-6. PubMed ID: 24050235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LITTLE FISH, BIG DATA: ZEBRAFISH AS A MODEL FOR CARDIOVASCULAR AND METABOLIC DISEASE.
    Gut P; Reischauer S; Stainier DYR; Arnaout R
    Physiol Rev; 2017 Jul; 97(3):889-938. PubMed ID: 28468832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.